AEON
Price:
$0.7485
Market Cap:
$8.72M
AEON Biopharma, Inc., a biopharmaceutical company, focuses on the development botulinum toxins for the treatment of debilitating medical conditions. It also develops 900 kDabotulinum toxin complex, ABP-450, for migraine, cervical dystonia, and gastroparesis. The company was formerly known as ALPHAEON Corporation and changed its name to AEON Biopharma, Inc. in December 2019. AEON Biopharma, Inc. was incorporated in 2012 and is headquartered in Newport Beach, California.
Industry
Biotechnology
IPO Date
2023-07-24
Stock Exchange
NASDAQ
Ticker
AEON
According to AEON Biopharma, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 0.90. This represents a change of 1.12% compared to the average of 0.89 of the last 4 quarters.
The mean historical Current Ratio of AEON Biopharma, Inc. over the last ten years is 2.04. The current 0.90 Current Ratio has changed 4.32% with respect to the historical average. Over the past ten years (40 quarters), AEON's Current Ratio was at its highest in in the December 2020 quarter at 4.85. The Current Ratio was at its lowest in in the September 2022 quarter at 0.
Average
2.04
Median
0.36
Minimum
0.11
Maximum
6.41
Discovering the peaks and valleys of AEON Biopharma, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 300.21%
Maximum Annual Current Ratio = 6.41
Minimum Annual Increase = -94.90%
Minimum Annual Current Ratio = 0.11
| Year | Current Ratio | Change |
|---|---|---|
| 2024 | 0.11 | -76.43% |
| 2023 | 0.48 | 300.21% |
| 2022 | 0.12 | -51.91% |
| 2021 | 0.25 | -94.90% |
| 2020 | 4.85 | -24.26% |
The current Current Ratio of AEON Biopharma, Inc. (AEON) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
0.24
5-year avg
1.16
10-year avg
2.04
AEON Biopharma, Inc.’s Current Ratio is less than Cingulate Inc. (1.26), less than Cellectar Biosciences, Inc. (2.15), less than Bolt Biotherapeutics, Inc. (3.57), less than Marker Therapeutics, Inc. (6.50), greater than OSR Holdings, Inc. (0.21), less than Clene Inc. (1.58), greater than Abpro Corporation (0.07), less than Mustang Bio, Inc. (1.30), greater than Aptorum Group Limited (0.22), less than Lyra Therapeutics, Inc. (2.78),
| Company | Current Ratio | Market cap |
|---|---|---|
| 1.26 | $22.09M | |
| 2.15 | $12.13M | |
| 3.57 | $10.18M | |
| 6.50 | $15.33M | |
| 0.21 | $17.76M | |
| 1.58 | $58.52M | |
| 0.07 | $12.91M | |
| 1.30 | $9.63M | |
| 0.22 | $10.00M | |
| 2.78 | $7.99M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like AEON Biopharma, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like AEON Biopharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is AEON Biopharma, Inc.'s Current Ratio?
How is the Current Ratio calculated for AEON Biopharma, Inc. (AEON)?
What is the highest Current Ratio for AEON Biopharma, Inc. (AEON)?
What is the 3-year average Current Ratio for AEON Biopharma, Inc. (AEON)?
What is the 5-year average Current Ratio for AEON Biopharma, Inc. (AEON)?
How does the current Current Ratio for AEON Biopharma, Inc. (AEON) compare to its historical average?